Evaluation of the BRIGHT intervention in primary care

Conditions

Chronic kidney disease Urological and Genital Diseases Chronic kidney disease

Thomas Blakeman, Christian Blickem, Anne Kennedy, David Reeves, Peter Bower et al. (17 authors)

PLoS ONE2014-10-1673 citations

10.1371/journal.pone.0109135

Aligning everyday life priorities with people’s self-management support networks: an exploration of the work and implementation of a needs-led telephone support system

Christian Blickem, Anne Kennedy, Praksha Jariwala, Rebecca Morris, Robert S. Bowen et al. (9 authors)

BMC Health Services Research2014-06-1740 citations

10.1186/1472-6963-14-262

The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial.

Blickem C, Blakeman T, Kennedy A, Bower P, Reeves D, Gardner C, Lee V, Chew-Graham C, Richardson G, Brooks H, Dawson S, Mossabir R, Jariwala P, Swallow A, Kontopantelis E, Gaffney H, Small N, Spackman E, Rogers A.

2013-01-2817 citations

10.1186/1745-6215-14-28

Interventions

The BRIGHT trial will evaluate an intervention aimed at addressing current gaps in care delivery for people with stage 3 CKD. The research is being carried in general practices across Greater Manches

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stage 3 chronic kidney disease (both stages 3a and 3b)

Exclusion criteria

Exclusion criteria: 1. Mental incapacity to provide informed consent 2. Unable to communicate in English 3. Receiving palliative care 4. Only one person per household will be eligible for the study to avoid contamination between control and intervention patients

Design outcomes

Primary

Measure	Time frame
All outcomes are at the level of the patient. The trial has three primary outcomes including: One clinical outcome of blood pressure control collected from the patients' general practice medical record, readings taken at time of baseline and 6 month review appointments. Two patient-reported outcomes of: 1. Self-management capacity (health education impact questionnaire (heiq) 2. Health-related quality of life (EQ5D) Each participant will complete a baseline questionnaire, and a follow-up questionnaire will be sent at 6 months.	—

Measure

Time frame

All outcomes are at the level of the patient. The trial has three primary outcomes including: One clinical outcome of blood pressure control collected from the patients' general practice medical record, readings taken at time of baseline and 6 month review appointments. Two patient-reported outcomes of: 1. Self-management capacity (health education impact questionnaire (heiq) 2. Health-related quality of life (EQ5D) Each participant will complete a baseline questionnaire, and a follow-up questionnaire will be sent at 6 months.

—

Secondary

Measure	Time frame
1. Anxiety: Hospital Anxiety and Depression scale (HADS) 2. CKD specific anxiety: Adaptation of an item from The Brief Illness Perceptions Questionnaire. 3. Loneliness: The UCLA Loneliness Scale 4. Medication Adherence: Adapted version of the Self-reported Measure of Medication-taking Scale 5. Social Capital: Health Survey for England 6. Social Networks 7. Service utilisation: modification of the service utilisation questionnaire from the national evaluation of the Expert Patients Programme. 8. Glycaemic control: (for patients with diabetes only, collected from patient's general practice medical records)	—

Measure

Time frame

1. Anxiety: Hospital Anxiety and Depression scale (HADS) 2. CKD specific anxiety: Adaptation of an item from The Brief Illness Perceptions Questionnaire. 3. Loneliness: The UCLA Loneliness Scale 4. Medication Adherence: Adapted version of the Self-reported Measure of Medication-taking Scale 5. Social Capital: Health Survey for England 6. Social Networks 7. Service utilisation: modification of the service utilisation questionnaire from the national evaluation of the Expert Patients Programme. 8. Glycaemic control: (for patients with diabetes only, collected from patient's general practice medical records)

—

Countries

United Kingdom

Outcome results

None listed